ArticleOPEN ACCESS

Management of ECD: The era of targeted therapies

Blood
DOI: 10.1182/blood.2020005803
5Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In this issue of Blood, Goyal and colleagues present the second consensus guidelines for the clinical diagnosis and treatment of patients with Erdheim-Chester disease (ECD), in the era of targeted therapies.

Cite

CITATION STYLE

APA

Abla, O. (2020, May 28). Management of ECD: The era of targeted therapies. Blood. American Society of Hematology. https://doi.org/10.1182/blood.2020005803

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free